Evidence of Liver Transplantation
30
0
1
14
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
13.3%
4 terminated out of 30 trials
77.8%
-8.7% vs benchmark
30%
9 trials in Phase 3/4
29%
4 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (30)
Immunogenicity of HPV Vaccine in Immunosuppressed Children
Quantifying Steatosis in Liver Transplant Donors
Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation
Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
Evaluate the Efficacy and Safety of the ADVAGRAF®
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)
Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver
Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)
Clinical Benefits of B-Flow Ultrasound
Changes of Macrophage Migration Inhibitory Factor During Orthotopic Liver Transplantation
A Pilot Trial of Pediatric Liver Transplantation Without Steroids
Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation
Study of Glycemic Control on Liver Transplantation Outcomes
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
Pilot Study of Hepatitis C Virus Entry Inhibitor (ITX 5061) in Liver Transplant Recipients
Clinical Trial of Hydrogen-Rich Celsior Solution Applied in Aging DBD Liver/Kidney Transplantation
Usefulness of Alpha-GST in Liver Transplantation
Uses of Immunosuppression Therapy in Patients With Liver Transplantation